간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
이미징 바이오 마커 시장. 글로벌 이미징 바이오 마커 시장 개요 글로벌 이미징 바이오 마커 시장 규모는 2021 년에 6,642 백만 달러에 이르렀으며 2022-2027 년 예측 기간 동안 14.1%의 CAGR로 증가했습니다. 바이오 마커는 조직, 혈액 또는 기타 체액에서 발견되는 생물학적 분자이며, 이는 정상 또는 비정상적인 과정 또는 상태 또는 질병의 존재를 나타냅니다
Summary
Imaging Biomarker Market. Global Imaging Biomarkers Market Overview Global Imaging Biomarkers Market size reached $6,642 million in 2021, growing at a CAGR of 14.1% during the forecast period 2022-2027. A biomarker is a biological molecule found in tissue, blood, or other body fluids, which marks the presence of a normal or an abnormal process, or of a condition or disease
Table of Contents
1. Imaging Biomarker Market - Overview
1.1 Definitions and Scope
2. Imaging Biomarker Market - Executive Summary
3. Imaging Biomarker Market – Comparative Analysis
3.1 Company Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split- Key Companies
3.4 Patent Analysis - Global
3.5 Pricing Analysis – Average Selling Price
4. Imaging Biomarker Market - Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Imaging Biomarker Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Imaging Biomarker Market – By Technology
6.1 Positron Emission Tomography
6.2 Ultrasound
6.3 Magnetic Resonance Imaging
6.4 Computed Tomography
6.5 Single-Photon Emission Computed Tomography
6.6 Others
7. Imaging Biomarker Market – By Application
7.1 Personalized Medicines
7.2 Drug Discovery and Development
7.3 Molecular Diagnostics
7.4 Drug Formulation
7.5 Disease Diagnosis
7.6 Forensic Applications
7.7 Others
8. Imaging Biomarker Market - By Geography
8.1 North America
8.1.1 U.S.
8.1.2 Mexico
8.1.3 Canada
8.2 Europe
8.2.1 U.K.
8.2.2 France
8.2.3 Germany
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 China
8.3.2 India
8.3.3 Japan
8.3.4 South Korea
8.3.5 Australia & New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Brazil
8.4.2 Argentina
8.4.3 Chile
8.4.4 Colombia
8.4.5 Rest of South America
8.5 Rest of the World
8.5.1 Middle East
8.5.2 Africa
9. Imaging Biomarker Market - Entropy
10. Imaging Biomarker Market Company Analysis
10.1 Company 1
10.2 Company 2
10.3 Company 3
10.4 Company 4
10.5 Company 5
10.6 Company 6
10.7 Company 7
10.8 Company 8
10.9 Company 9
10.10 Company 10
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
이미징 바이오 마커 시장. 글로벌 이미징 바이오 마커 시장 개요 글로벌 이미징 바이오 마커 시장 규모는 2021 년에 6,642 백만 달러에 이르렀으며 2022-2027 년 예측 기간 동안 14.1%의 CAGR로 증가했습니다. 바이오 마커는 조직, 혈액 또는 기타 체액에서 발견되는 생물학적 분자이며, 이는 정상 또는 비정상적인 과정 또는 상태 또는 질병의 존재를 나타냅니다
Summary
Imaging Biomarker Market. Global Imaging Biomarkers Market Overview Global Imaging Biomarkers Market size reached $6,642 million in 2021, growing at a CAGR of 14.1% during the forecast period 2022-2027. A biomarker is a biological molecule found in tissue, blood, or other body fluids, which marks the presence of a normal or an abnormal process, or of a condition or disease
Table of Contents
1. Imaging Biomarker Market - Overview
1.1 Definitions and Scope
2. Imaging Biomarker Market - Executive Summary
3. Imaging Biomarker Market – Comparative Analysis
3.1 Company Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split- Key Companies
3.4 Patent Analysis - Global
3.5 Pricing Analysis – Average Selling Price
4. Imaging Biomarker Market - Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Imaging Biomarker Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Imaging Biomarker Market – By Technology
6.1 Positron Emission Tomography
6.2 Ultrasound
6.3 Magnetic Resonance Imaging
6.4 Computed Tomography
6.5 Single-Photon Emission Computed Tomography
6.6 Others
7. Imaging Biomarker Market – By Application
7.1 Personalized Medicines
7.2 Drug Discovery and Development
7.3 Molecular Diagnostics
7.4 Drug Formulation
7.5 Disease Diagnosis
7.6 Forensic Applications
7.7 Others
8. Imaging Biomarker Market - By Geography
8.1 North America
8.1.1 U.S.
8.1.2 Mexico
8.1.3 Canada
8.2 Europe
8.2.1 U.K.
8.2.2 France
8.2.3 Germany
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 China
8.3.2 India
8.3.3 Japan
8.3.4 South Korea
8.3.5 Australia & New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Brazil
8.4.2 Argentina
8.4.3 Chile
8.4.4 Colombia
8.4.5 Rest of South America
8.5 Rest of the World
8.5.1 Middle East
8.5.2 Africa
9. Imaging Biomarker Market - Entropy
10. Imaging Biomarker Market Company Analysis
10.1 Company 1
10.2 Company 2
10.3 Company 3
10.4 Company 4
10.5 Company 5
10.6 Company 6
10.7 Company 7
10.8 Company 8
10.9 Company 9
10.10 Company 10
